Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Exchange Rate Effect: 2020-2024

Historic Exchange Rate Effect for NewAmsterdam Pharma Co N.V (NAMS) over the last 5 years, with Dec 2024 value amounting to -$6.8 million.

  • NewAmsterdam Pharma Co N.V's Exchange Rate Effect fell 95.11% to $222,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 23.18%. This contributed to the annual value of -$6.8 million for FY2024, which is 234.64% down from last year.
  • Latest data reveals that NewAmsterdam Pharma Co N.V reported Exchange Rate Effect of -$6.8 million as of FY2024, which was down 234.64% from $5.1 million recorded in FY2023.
  • In the past 5 years, NewAmsterdam Pharma Co N.V's Exchange Rate Effect ranged from a high of $5.2 million in FY2022 and a low of -$6.8 million during FY2024.
  • Over the past 3 years, NewAmsterdam Pharma Co N.V's median Exchange Rate Effect value was $5.1 million (recorded in 2023), while the average stood at $1.2 million.
  • As far as peak fluctuations go, NewAmsterdam Pharma Co N.V's Exchange Rate Effect slumped by 17,189.64% in 2021, and later soared by 212.06% in 2022.
  • Yearly analysis of 5 years shows NewAmsterdam Pharma Co N.V's Exchange Rate Effect stood at $27,403 in 2020, then slumped by 17,189.64% to -$4.7 million in 2021, then surged by 212.06% to $5.2 million in 2022, then dropped by 3.73% to $5.1 million in 2023, then slumped by 234.64% to -$6.8 million in 2024.